Author: Day One Biopharmaceuticals, Inc.

Posted Date:

March 6, 2026

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio

Day One Biopharmaceuticals, Inc.

March 6, 2026
Day One Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Outlook and Revenue Guidance

Day One Biopharmaceuticals, Inc.

February 24, 2026
Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026

Day One Biopharmaceuticals, Inc.

February 10, 2026